Ritsuko Koketsu-Kubota

Osaka, 5650871, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Antibodies against dengue virus in COVID-19 patients in Japan: a dengue virus non-endemic country.

Antibodies against dengue virus in COVID-19 patients in Japan: a dengue virus non-endemic country.

Journal: Tropical medicine and health
Published: April 23, 2026

Immune Correlates of Denileukin Diftitox Treatment in TFH-Type Lymphoma.

Immune Correlates of Denileukin Diftitox Treatment in TFH-Type Lymphoma.

Journal: Cancers
Published: March 27, 2026

Activated Memory Cytotoxic T-Lymphocytes and T-Cell Receptor Vβ Clonality Predict Treatment-Free Remission After Tyrosine Kinase Inhibitor Discontinuation in Chronic-Phase Chronic Myeloid Leukemia: A 1-Year Prospective Immuno-Monitoring Study.

Activated Memory Cytotoxic T-Lymphocytes and T-Cell Receptor Vβ Clonality Predict Treatment-Free Remission After Tyrosine Kinase Inhibitor Discontinuation in Chronic-Phase Chronic Myeloid Leukemia: A 1-Year Prospective Immuno-Monitoring Study.

Journal: International journal of molecular sciences
Published: January 09, 2026

An Improved Dengue Virus Serotype-Specific Non-Structural Protein 1 Capture Immunochromatography Method with Reduced Sample Volume.

An Improved Dengue Virus Serotype-Specific Non-Structural Protein 1 Capture Immunochromatography Method with Reduced Sample Volume.

Journal: Biosensors
Published: October 27, 2025

Dengue virus type 3 infection in a traveler returning from Costa Rica to Japan in 2023.

Dengue virus type 3 infection in a traveler returning from Costa Rica to Japan in 2023.

Journal: Tropical medicine and health
Published: April 16, 2024

Anti-monkeypox virus-neutralizing activities of human immunoglobulin manufactured between 1999 and 2021 and derived from donors in the United States and Japan.

Anti-monkeypox virus-neutralizing activities of human immunoglobulin manufactured between 1999 and 2021 and derived from donors in the United States and Japan.

Journal: Vox sanguinis
Published: January 29, 2024

Changes in Anti-SARS-CoV-2 Antibody Titers of Pooled Plasma Derived From Donors in Japan: A Potential Tool for Mass-Immunity Evaluation.

Changes in Anti-SARS-CoV-2 Antibody Titers of Pooled Plasma Derived From Donors in Japan: A Potential Tool for Mass-Immunity Evaluation.

Journal: The Journal of infectious diseases
Published: January 13, 2023

Decline in intravenous immunoglobulin titer against influenza virus A/H2N2 derived from donors in Japan.

Decline in intravenous immunoglobulin titer against influenza virus A/H2N2 derived from donors in Japan.

Journal: Journal of medical virology
Published: November 20, 2022

COVID-19 relapse associated with SARS-CoV-2 evasion from CD4+ T-cell recognition in an agammaglobulinemia patient.

COVID-19 relapse associated with SARS-CoV-2 evasion from CD4+ T-cell recognition in an agammaglobulinemia patient.

Journal: iScience
Published: June 30, 2022

Live attenuated VZV vaccination induces antitumor immunity in ATLL patients.

Live attenuated VZV vaccination induces antitumor immunity in ATLL patients.

Journal: Cancer immunology, immunotherapy : CII
Published: May 07, 2022

Anti-nucleocapsid antibodies enhance the production of IL-6 induced by SARS-CoV-2 N protein.

Anti-nucleocapsid antibodies enhance the production of IL-6 induced by SARS-CoV-2 N protein.

Journal: Scientific reports
Published: February 02, 2022

Preclinical study of a DNA vaccine targeting SARS-CoV-2.

Preclinical study of a DNA vaccine targeting SARS-CoV-2.

Journal: Current research in translational medicine
Published: August 10, 2021
Showing 1-12 of 35

Last Updated: 09/26/2026